Daiwa Securities Group’s Karyopharm Therapeutics KPTI Stock Holding History

Daiwa Securities Group’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9	Closed	–	–	1358
2023 Q3	$0	Hold	9	–	–	﹤0.01%	1314
2023 Q2	$0	Hold	9	–	–	﹤0.01%	1337
2023 Q1	$1K	Hold	9	–	–	﹤0.01%	1260
2022 Q4	$0	Hold	9	–	–	﹤0.01%	1346
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	1296
2022 Q2	$1K	Hold	9	–	–	﹤0.01%	1296
2022 Q1	$1K	Hold	9	–	–	﹤0.01%	1315
2021 Q4	$1K	Hold	9	–	–	﹤0.01%	1343
2021 Q3	$1K	Hold	9	–	–	﹤0.01%	1273
2021 Q2	$1K	Hold	9	–	–	﹤0.01%	1199
2021 Q1	$1K	Hold	9	–	–	﹤0.01%	1207
2020 Q4	$2K	Sell	9 -19	-68%	-$4.4K	﹤0.01%	1124
2020 Q3	$6K	Buy	28 +4	+17%	+$978	﹤0.01%	1076
2020 Q2	$7K	Hold	24	–	–	﹤0.01%	1088
2020 Q1	$7K	Hold	24	–	–	﹤0.01%	1081
2019 Q4	$7K	Sell	24 -2	-8%	-$434	﹤0.01%	1087
2019 Q3	$4K	Hold	26	–	–	﹤0.01%	1088
2019 Q2	$2K	Buy	26 +9	+53%	+$723	﹤0.01%	1148
2019 Q1	$2K	Hold	17	–	–	﹤0.01%	1133
2018 Q4	$2K	Hold	17	–	–	﹤0.01%	1107
2018 Q3	$4K	Hold	17	–	–	﹤0.01%	1092
2018 Q2	$4K	Hold	17	–	–	﹤0.01%	1109
2018 Q1	$4K	Buy	+17	New	+$3.39K	﹤0.01%	1089

Other funds holding KPTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Daiwa Securities Group's KPTI Position: Q4 2023 in Review

Daiwa Securities Group sold out of Karyopharm Therapeutics (KPTI) in Q4 2023, closing a stake of 9 shares.

Daiwa Securities Group first reported a position in KPTI in Q1 2018 and held it in 23 quarters. The position peaked at $7K in Q2 2020. 117 funds tracked by Wall St. Rank hold KPTI as of Q4 2023.

Daiwa Securities Group reported no remaining Karyopharm Therapeutics position as of Q4 2023 after selling out during the quarter.
Daiwa Securities Group sold 9 Karyopharm Therapeutics shares in Q4 2023.
Daiwa Securities Group first reported a position in Karyopharm Therapeutics in Q1 2018 and held it in 23 quarters.
Daiwa Securities Group's Karyopharm Therapeutics position peaked at $7K in Q2 2020.
117 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.